LONG WALK MANAGEMENT LP

Long Walk Management LP is a Boston-based investment management firm that files quarterly 13F reports with the Securities and Exchange Commission under CIK #0001869470. The firm operates as a hedge fund structure, managing concentrated equity portfolios with a fundamental, research-driven investment approach. Long Walk Management was founded by Adam Smalley, a seasoned investment professional whose career in institutional equity investing preceded the launch of this independent investment vehicle. The firm's CIK registration dates to the early 2020s, identifying Long Walk Management as a relatively recent entrant to the 13F filing universe. This timeline is consistent with a fund launch during a period of significant capital formation in the alternative investment space, when experienced portfolio managers from established institutional platforms increasingly pursued independent fund launches to deploy their investment processes with greater autonomy and alignment. The Boston location places Long Walk Management within one of the most concentrated ecosystems of investment management talent in the world — a city whose financial district and surrounding communities house hundreds of hedge funds, mutual fund complexes, and institutional asset managers, providing access to a deep research network, experienced investment professionals, and a sophisticated institutional investor base. As a hedge fund manager, Long Walk Management operates with the structural flexibility characteristic of limited partnership vehicles — the ability to size positions with high conviction, manage net exposure dynamically, and pursue investment opportunities across the market capitalization spectrum without the benchmark-relative constraints that govern most traditional asset managers. The firm's 13F filings provide a window into its long equity portfolio, documenting the disclosed positions that constitute the public equity component of what may include both long and short exposures within the overall fund strategy.

Long Walk Management LP pursues a fundamental, research-intensive investment strategy focused on identifying high-quality companies with durable competitive advantages, strong growth trajectories, and attractive risk-reward profiles. The firm's approach is rooted in deep, bottom-up analysis of individual businesses — evaluating management quality, addressable market dynamics, competitive positioning, unit economics, and capital allocation discipline to construct a concentrated portfolio of the firm's highest-conviction investment ideas. The firm's 13F Portfolio Composition reveals a portfolio that typically holds a focused number of positions across the technology, healthcare, and consumer sectors — industries characterized by innovation-driven growth dynamics, scalable business models, and significant opportunity for differentiated fundamental research to generate informational advantage. Within technology, the firm appears to favor companies benefiting from secular digitalization trends, software adoption cycles, cloud computing expansion, and other structural shifts in enterprise and consumer technology spending. Healthcare positions may encompass pharmaceutical, biotech, and medical technology companies where proprietary pipeline analysis, regulatory pathway assessment, and clinical trial evaluation create opportunities for fundamental insight that differs from consensus expectations. Examination of Top 10 Holdings Concentration across the firm's quarterly filings reveals a portfolio with meaningful position sizing in the firm's best ideas — a concentration profile consistent with a high-conviction hedge fund that allocates capital deliberately to a manageable number of thoroughly researched positions rather than diversifying broadly across dozens of names. This concentrated approach reflects the belief that superior long-term compounding behavior is achieved by deploying meaningful capital behind a portfolio manager's highest-confidence investment theses, provided those theses are supported by rigorous fundamental work. The investment style is best characterized as long-biased fundamental growth, where the firm seeks companies whose growth potential is underappreciated by the market and whose intrinsic value will compound over a multi-year horizon as the business executes on its strategic plan. While the 13F filings capture only the long equity portfolio, the hedge fund structure affords the flexibility to manage net exposure through short positions, hedging instruments, or cash management — capabilities that may influence overall fund risk-return characteristics in ways not fully visible through 13F disclosures alone. Turnover appears to be moderate, consistent with an investment process that establishes positions with a multi-quarter to multi-year holding period but actively manages the portfolio as investment theses play out, new opportunities emerge, or fundamental developments alter the risk-reward calculus of existing holdings. This dynamic portfolio management approach distinguishes Long Walk Management from purely buy-and-hold strategies while maintaining sufficient holding period discipline to allow compounding dynamics to develop within individual positions. INVESTMENT RISK PROFILE The risk profile of Long Walk Management LP is defined by several interconnected factors: concentrated position sizing, growth-oriented sector exposure, and the structural characteristics of a hedge fund vehicle managing a focused equity portfolio. These elements combine to create a return distribution that may exhibit higher dispersion than diversified equity strategies — with the potential for both meaningful outperformance and significant drawdowns depending on market conditions and the trajectory of the firm's individual investment theses. Max Drawdown Depth is a critical risk dimension for concentrated growth-oriented portfolios. During periods when growth equities experience broad-based selling pressure — as occurred during the aggressive interest rate tightening cycle of 2022, when duration-sensitive growth stocks underwent dramatic multiple compression — a concentrated portfolio of technology and healthcare growth names can experience drawdowns that significantly exceed broad market declines. The firm's filing history encompasses the 2022 growth equity correction, providing an important data point for evaluating how the portfolio navigated one of the most challenging environments for growth-oriented strategies in recent memory. The Volatility Profile of Long Walk Management's disclosed portfolio is likely elevated relative to broad equity benchmarks, reflecting both the concentration of positions and the inherently higher beta characteristics of technology and healthcare growth equities. Individual position volatility can be amplified by earnings-driven price movements, regulatory developments in healthcare, shifts in technology spending patterns, and changes in the macroeconomic outlook that affect the discount rates applied to long-duration growth assets. At the portfolio level, this volatility may be partially mitigated by diversification across subsectors and by any hedging activities deployed within the broader fund structure that are not visible through 13F filings. Key-person risk is a relevant consideration, as the firm's investment process appears to be closely tied to the founder's analytical framework and investment philosophy. In smaller, founder-led hedge fund operations, the departure or incapacitation of the principal investment professional represents a structural risk that could fundamentally alter the fund's character and capital trajectory. Factor exposure risk warrants attention as well. A portfolio concentrated in growth equities carries implicit exposure to the growth factor, interest rate sensitivity, and momentum dynamics. During factor rotations — when value outperforms growth, or when defensive sectors lead cyclicals — the firm's concentrated growth positioning may experience sustained underperformance relative to the broad market, even if individual company fundamentals remain intact. Understanding the portfolio's factor loadings through quantitative decomposition adds an important analytical layer beyond traditional fundamental evaluation.

Long Walk Management LP represents a focused, fundamental growth-oriented hedge fund operating from Boston's deep institutional investment ecosystem. The firm's 13F filing record under CIK #0001869470, while relatively brief given its early-2020s establishment, provides a growing body of data for evaluating its concentrated equity positioning, sector preferences, and portfolio construction methodology. Key analytical dimensions for evaluating the firm's capital trajectory include Annualized Return (CAGR) derived from historical replication of disclosed long positions, normalized to a user-defined notional through the platform's portfolio simulator. Given the concentrated, growth-oriented nature of the portfolio, the Sortino Ratio is a particularly instructive efficiency metric, as it isolates downside deviation and provides a more nuanced assessment of risk-adjusted outcomes than symmetric volatility measures for a strategy that may exhibit meaningful return skewness. Sector Allocation History traced through sequential 13F filings reveals the evolution of the firm's thematic positioning — whether the portfolio has maintained consistent sector concentrations or shifted emphasis across technology, healthcare, and consumer subsectors in response to changing market opportunities. The platform's backtesting service enables historical replication of Long Walk Management's disclosed holdings across the market environments captured in its filing history, including the post-pandemic growth equity rally, the 2022 rate-shock drawdown, and the subsequent recovery dynamics of 2023–2024. This range of market conditions, while compressed into a relatively short time frame, encompasses meaningful regime diversity — from ultra-accommodative monetary policy to aggressive tightening and back to cautious easing — providing a useful if limited window into how the firm's concentrated growth approach responds to macroeconomic regime transitions. As the firm's filing history lengthens, each additional quarterly disclosure will enhance the statistical robustness of analytical conclusions and provide greater confidence in identifying structural biases, conviction patterns, and adaptive tendencies within the investment process. Analysts evaluating Long Walk Management should pay particular attention to how position sizing evolves across market cycles and whether the firm demonstrates the ability to preserve capital during adverse growth equity environments. A critical diagnostic question for forward-looking evaluation: given that Long Walk Management's concentrated growth equity approach launched into and navigated one of the most volatile periods for growth factor returns in modern market history, does the firm's observable portfolio behavior during the 2022 drawdown and subsequent recovery reveal a structural commitment to growth factor exposure regardless of regime — or evidence of tactical adaptation in concentration levels and sector emphasis that suggests dynamic sensitivity to shifting interest rate and liquidity conditions?